Total Payments
$10,883
2024 Payments
$4,565
Companies
42
Transactions
488
Medicare Patients
13,032
Medicare Billing
$538,648
Payment Breakdown by Category
Food & Beverage$8,060 (74.1%)
Travel$2,031 (18.7%)
Consulting$485.00 (4.5%)
Education$306.36 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,060 | 476 | 74.1% |
| Travel and Lodging | $2,031 | 5 | 18.7% |
| Consulting Fee | $485.00 | 1 | 4.5% |
| Education | $306.36 | 6 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $3,637 | 49 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $1,304 | 96 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $912.57 | 72 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $562.00 | 37 | $0 (2024) |
| Medtronic Vascular, Inc. | $397.24 | 23 | $0 (2020) |
| Amgen Inc. | $384.44 | 21 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $379.91 | 23 | $0 (2020) |
| Abbott Laboratories | $345.36 | 11 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $307.41 | 12 | $0 (2024) |
| PFIZER INC. | $288.12 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,565 | 105 | Medtronic, Inc. ($3,078) |
| 2023 | $846.06 | 45 | Novartis Pharmaceuticals Corporation ($202.53) |
| 2022 | $542.20 | 23 | Medtronic, Inc. ($331.34) |
| 2021 | $187.46 | 8 | Abbott Laboratories ($105.00) |
| 2020 | $486.09 | 29 | Medtronic Vascular, Inc. ($122.23) |
| 2019 | $1,514 | 98 | Janssen Pharmaceuticals, Inc ($267.66) |
| 2018 | $1,513 | 91 | Janssen Pharmaceuticals, Inc ($261.65) |
| 2017 | $1,229 | 89 | Novartis Pharmaceuticals Corporation ($223.55) |
All Payment Transactions
488 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $44.47 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.27 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/13/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/05/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/15/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $27.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $10.54 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/31/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/23/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $31.25 | General |
| Category: Coronary | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $8.77 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $6.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.92 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $7.42 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $23.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/17/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/09/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Pacemakers | ||||||
| 09/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $28.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/22/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/21/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/15/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.30 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/14/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Education | In-kind items and services | $88.99 | General |
| Category: Cardiology | ||||||
| 08/14/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 3,027 | 3,591 | $368,204 | $120,069 |
| 2022 | 25 | 3,449 | 4,126 | $400,381 | $136,750 |
| 2021 | 23 | 3,364 | 4,171 | $357,014 | $137,956 |
| 2020 | 27 | 3,192 | 4,108 | $381,815 | $143,873 |
Total Patients
13,032
Total Services
15,996
Medicare Billing
$538,648
Procedure Codes
103
All Medicare Procedures & Services
103 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 449 | 491 | $88,380 | $26,591 | 30.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 296 | 303 | $41,814 | $14,826 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 163 | $40,750 | $13,564 | 33.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 105 | 182 | $25,239 | $10,931 | 43.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 60 | 63 | $22,428 | $7,961 | 35.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 52 | 78 | $16,144 | $6,972 | 43.2% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 128 | 128 | $22,014 | $6,634 | 30.1% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 34 | 34 | $19,826 | $6,447 | 32.5% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 668 | 1,031 | $18,558 | $6,322 | 34.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 50 | $12,000 | $4,427 | 36.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 394 | 406 | $16,646 | $3,449 | 20.7% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 141 | 141 | $6,204 | $2,070 | 33.4% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 37 | 42 | $4,152 | $1,579 | 38.0% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 141 | 141 | $4,371 | $1,387 | 31.7% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 13 | 16 | $3,456 | $1,269 | 36.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 18 | 18 | $4,356 | $1,081 | 24.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $5,040 | $1,007 | 20.0% |
| 93289 | Evaluation of single, dual, or multiple lead implantable defibrillator system | Office | 2023 | 17 | 19 | $2,388 | $812.17 | 34.0% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 71 | 74 | $6,508 | $688.20 | 10.6% |
| 93272 | Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring, transmission and review and report by health care professional | Facility | 2023 | 38 | 38 | $2,280 | $651.00 | 28.6% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 30 | 30 | $1,380 | $554.77 | 40.2% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 28 | 28 | $1,344 | $379.72 | 28.3% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 33 | 35 | $770.00 | $185.30 | 24.1% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 21 | 21 | $1,211 | $175.20 | 14.5% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 41 | 45 | $945.00 | $104.41 | 11.0% |
About Dr. William Espar, M.D
Dr. William Espar, M.D is a Internal Medicine healthcare provider based in Michigan City, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1952396855.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Espar, M.D has received a total of $10,883 in payments from pharmaceutical and medical device companies, with $4,565 received in 2024. These payments were reported across 488 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($8,060).
As a Medicare-enrolled provider, Espar has provided services to 13,032 Medicare beneficiaries, totaling 15,996 services with total Medicare billing of $538,648. Data is available for 4 years (2020–2023), covering 103 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Interventional Cardiology, Diagnostic Ultrasound
- Location Michigan City, IN
- Active Since 09/16/2005
- Last Updated 06/20/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1952396855
Products in Payments
- ATTAIN COMMAND + SUREVALVE (Device) $1,337
- ENTRESTO (Drug) $989.35
- XARELTO (Drug) $912.57
- LifeVest (Device) $562.00
- AZURE XT DR MRI SURESCAN (Device) $383.67
- PRALUENT (Drug) $358.89
- ELIQUIS (Drug) $324.58
- LEQVIO (Drug) $314.25
- Micra (Device) $287.80
- Impella (Device) $207.63
- Corlanor (Drug) $182.66
- Repatha (Biological) $181.58
- CARDIOMEMS (Device) $180.35
- MICRA (Device) $170.96
- COREVALVE EVOLUT R (Device) $144.61
- OPSUMIT (Drug) $141.51
- Azure (Device) $123.96
- OPSUMIT MACITENTAN (Drug) $120.59
- PRADAXA (Drug) $105.80
- CHANTIX (Drug) $104.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Michigan City
David Villafuerte Martinez, Md, MD
Internal Medicine — Payments: $10,870
Internal Medicine $10,870
Mohammad Arfeen
Internal Medicine — Payments: $7,023
Internal Medicine $7,023
Malek Maatouk, M.d, M.D
Internal Medicine — Payments: $5,317
Internal Medicine $5,317
Dr. Vidya Kora, Md, MD
Internal Medicine — Payments: $4,155
Internal Medicine $4,155
Bikash Agarwal, Md, MD
Internal Medicine — Payments: $4,121
Internal Medicine $4,121
James Pickford, Md, MD
Internal Medicine — Payments: $3,567
Internal Medicine $3,567